Major points and concepts to consider when offering pan-ethnic expanded carrier testing
September 17th 2020The following points summarize information from a Joint Statement of the Perinatal Quality Foundation, ACMG, ACOG, the Society for Maternal-Fetal Medicine (SMFM), and the National Society of Genetic Counselors on “points to consider” when performing expanded carrier screening in reproductive medicine.
FDA safety alert: Efficacy concerns for a combination therapy in breast cancer treatment
September 16th 2020Officials from the Food and Drug Administration (FDA) issued a safety alert on Sept. 8 about potential efficacy and safety concerns with Tecentriq in combination with Paclitaxel for breast cancer treatment.
Little evidence supports the routine use of activity restriction for preterm birth and other obstetric conditions, and some data indicate adverse impact on obstetric outcomes.